Natural Medicine Division 2027 Regulatory Agenda

CDOR Natural Medicine Division Regulatory Agenda

The Colorado Department of Revenue (CDOR) submits the following 2027 Regulatory Agenda (Agenda) in fulfillment of the statutory requirements set forth in §2-7-202(6), 2-7-203, and 24-4-103.3(4), C.R.S. Pursuant to state law, annually on November 1 executive-branch agencies must file their Agenda. 
Per §2-7- 202(6), C.R.S., the Agenda must contain: 

  • (a) A list of new rules or revisions to existing rules that the department expects to propose in the next calendar year;
  • (b) The statutory or other basis for adoption of the proposed rules;
  • (c) The purpose of the proposed rules;
  • (d) The contemplated schedule for adoption of the rules;
  • (e) An identification and listing of persons or parties that may be affected positively or negatively by the rules.

The Agenda is to be filed with Legislative Council Staff for distribution to committee(s) of reference, posted on CDOR’s website, and submitted to the State Library, the Colorado Department of Regulatory Agencies, and the Secretary of State for publication in the Colorado Register. CDOR must also present its Agenda as part of its “SMART Act” presentation pursuant to §2-7-203(2)(a), C.R.S. CDOR works with several boards and commissions that promulgate rules; for ease of use for the consumer, those rules are included in CDOR's Agenda. The Agenda covers Calendar Year 2027(CY27).

Division of Natural Medicine 2027 Regulatory Agenda
Schedule (month)Rule Number and Title (or Description) (ex: 1 CCR 201-1, Rule #101)New rule, revision, or repeal?Statutory or other basis for adoption of rule (ex: 2-3-401, C.R.S.)Part of Mandatory Rule Review? X if yesPurpose (Purpose for the change, ex: legislation)StakeholdersAnticipated Hearing Date
Jul.1 CCR 213-1 Rule 2005Revision44-50-104(2), 44-50-202(1)(b), 44-50-203(1)(a), 44-50-203(1)(c), 44-50-203(2)(a), 44-50-601(2)-(3), and 44-50-602, C.R.S.XAnnual required fee reviewNMD Stakeholder ListSummer 2027
Jul.2 CCR 213-1 Rule 1025Revision44-50-103, 44-50-202(1)(b), 44-50-203(1)(d), 44-50-203(1)(n), 44-50-203(2)(a), 44-50-203(2)(g), and 44-50-203(2)(r), C.R.S. Update Adverse Health Event definition to reflect changes from CDPHE and DORACDPHE, DORA, Natural Medicine business stakeholdersSummer 2027